> top > docs > PubMed:21237297 > annotations

PubMed:21237297 JSONTXT

Annnotations TAB JSON ListView MergeView

GlyCosmos600-CLO

Id Subject Object Predicate Lexical cue
T1 114-124 http://purl.obolibrary.org/obo/CL_0000066 denotes Epithelial
T2 666-670 http://purl.obolibrary.org/obo/GO_0005623 denotes cell
T3 816-820 http://purl.obolibrary.org/obo/GO_0005623 denotes cell
T4 827-835 http://purl.obolibrary.org/obo/CLO_0009384 denotes TOV-112D
T5 840-847 http://purl.obolibrary.org/obo/CLO_0009385 denotes TOV-21G
T6 1155-1159 http://purl.obolibrary.org/obo/GO_0005623 denotes cell
T7 1219-1230 http://purl.obolibrary.org/obo/CLO_0053221 denotes hybrid cell
T8 1219-1230 http://purl.obolibrary.org/obo/CLO_0053220 denotes hybrid cell
T9 1219-1230 http://purl.obolibrary.org/obo/CLO_0053219 denotes hybrid cell
T10 1424-1428 http://purl.obolibrary.org/obo/GO_0005623 denotes cell

Glycosmos6-MAT

Id Subject Object Predicate Lexical cue
T1 441-446 http://purl.obolibrary.org/obo/MAT_0000083 denotes blood
T2 441-446 http://purl.obolibrary.org/obo/MAT_0000315 denotes blood

sentences

Id Subject Object Predicate Lexical cue
TextSentencer_T1 0-113 Sentence denotes Profiling signatures of ovarian cancer tumour suppression using 2D-DIGE and 2D-LC-MS/MS with tandem mass tagging.
TextSentencer_T2 114-273 Sentence denotes Epithelial ovarian cancer (EOC) is the most common form of gynaecological malignancy in the developed world and has a poor prognosis due to its late detection.
TextSentencer_T3 274-431 Sentence denotes Identifying molecular markers of the disease may provide novel approaches to screening and could enable targeted treatment and the design of novel therapies.
TextSentencer_T4 432-701 Sentence denotes Although blood is recognized as a highly important source of disease-related biomarkers, the complexity and dynamic range of protein abundance in body fluids has hampered proteomic biomarker discovery and alternative approaches using cell models may be more successful.
TextSentencer_T5 702-921 Sentence denotes Herein, we have utilized two cellular models of EOC, where transfer of normal chromosome 18 material into the EOC cell lines TOV-112D and TOV-21G induced in vitro and in vivo suppression of their tumourigenic phenotype.
TextSentencer_T6 922-1327 Sentence denotes A combination of quantitative two-dimensional difference gel electrophoresis (2D-DIGE) and two-dimensional-liquid chromatography tandem mass spectrometry (2D-LC-MS/MS) with tandem mass tagging (TMT) was employed to examine the whole cell, secreted and crude membrane proteomes of the parental and hybrid cell models to identify differentially expressed proteins as potential markers of tumour suppression.
TextSentencer_T7 1328-1486 Sentence denotes Protein changes of interest were confirmed by immunoblotting in additional hybrid and revertant cell lines where incorporated chromosome 18 material was lost.
TextSentencer_T8 1487-1580 Sentence denotes One candidate marker was also tested in sera from a set of ovarian cancer cases and controls.
TextSentencer_T9 1581-1693 Sentence denotes We have identified a list of promising candidate biomarkers for further testing and functional characterization.
T1 0-113 Sentence denotes Profiling signatures of ovarian cancer tumour suppression using 2D-DIGE and 2D-LC-MS/MS with tandem mass tagging.
T2 114-273 Sentence denotes Epithelial ovarian cancer (EOC) is the most common form of gynaecological malignancy in the developed world and has a poor prognosis due to its late detection.
T3 274-431 Sentence denotes Identifying molecular markers of the disease may provide novel approaches to screening and could enable targeted treatment and the design of novel therapies.
T4 432-701 Sentence denotes Although blood is recognized as a highly important source of disease-related biomarkers, the complexity and dynamic range of protein abundance in body fluids has hampered proteomic biomarker discovery and alternative approaches using cell models may be more successful.
T5 702-921 Sentence denotes Herein, we have utilized two cellular models of EOC, where transfer of normal chromosome 18 material into the EOC cell lines TOV-112D and TOV-21G induced in vitro and in vivo suppression of their tumourigenic phenotype.
T6 922-1327 Sentence denotes A combination of quantitative two-dimensional difference gel electrophoresis (2D-DIGE) and two-dimensional-liquid chromatography tandem mass spectrometry (2D-LC-MS/MS) with tandem mass tagging (TMT) was employed to examine the whole cell, secreted and crude membrane proteomes of the parental and hybrid cell models to identify differentially expressed proteins as potential markers of tumour suppression.
T7 1328-1486 Sentence denotes Protein changes of interest were confirmed by immunoblotting in additional hybrid and revertant cell lines where incorporated chromosome 18 material was lost.
T8 1487-1580 Sentence denotes One candidate marker was also tested in sera from a set of ovarian cancer cases and controls.
T9 1581-1693 Sentence denotes We have identified a list of promising candidate biomarkers for further testing and functional characterization.

PubmedHPO

Id Subject Object Predicate Lexical cue
T1 125-139 HP_0100615 denotes ovarian cancer
T2 133-139 HP_0002664 denotes cancer
T3 1308-1314 HP_0002664 denotes tumour
T4 1546-1560 HP_0100615 denotes ovarian cancer
T5 1554-1560 HP_0002664 denotes cancer

Allie

Id Subject Object Predicate Lexical cue
SS1_21237297_1_0 114-139 expanded denotes Epithelial ovarian cancer
SS2_21237297_1_0 141-144 abbr denotes EOC
SS1_21237297_5_0 1095-1114 expanded denotes tandem mass tagging
SS2_21237297_5_0 1116-1119 abbr denotes TMT
AE1_21237297_1_0 SS1_21237297_1_0 SS2_21237297_1_0 abbreviatedTo Epithelial ovarian cancer,EOC
AE1_21237297_5_0 SS1_21237297_5_0 SS2_21237297_5_0 abbreviatedTo tandem mass tagging,TMT

GlyCosmos600-FMA

Id Subject Object Predicate Lexical cue fma_id
T1 441-446 Body_part denotes blood http://purl.org/sig/ont/fma/fma9670
T2 557-564 Body_part denotes protein http://purl.org/sig/ont/fma/fma67257
T3 578-589 Body_part denotes body fluids http://purl.org/sig/ont/fma/fma280556
T4 578-582 Body_part denotes body http://purl.org/sig/ont/fma/fma256135
T5 666-670 Body_part denotes cell http://purl.org/sig/ont/fma/fma68646
T6 780-790 Body_part denotes chromosome http://purl.org/sig/ont/fma/fma67093
T7 816-820 Body_part denotes cell http://purl.org/sig/ont/fma/fma68646
T8 1155-1159 Body_part denotes cell http://purl.org/sig/ont/fma/fma68646
T9 1226-1230 Body_part denotes cell http://purl.org/sig/ont/fma/fma68646
T10 1275-1283 Body_part denotes proteins http://purl.org/sig/ont/fma/fma67257
T11 1328-1335 Body_part denotes Protein http://purl.org/sig/ont/fma/fma67257
T12 1424-1428 Body_part denotes cell http://purl.org/sig/ont/fma/fma68646
T13 1454-1464 Body_part denotes chromosome http://purl.org/sig/ont/fma/fma67093

GlyCosmos600-MAT

Id Subject Object Predicate Lexical cue
PD-MAT-B_T1 441-446 http://purl.obolibrary.org/obo/MAT_0000083 denotes blood
PD-MAT-B_T2 441-446 http://purl.obolibrary.org/obo/MAT_0000315 denotes blood

pubmed-enju-pas

Id Subject Object Predicate Lexical cue
EnjuParser_T0 0-9 VBG denotes Profiling
EnjuParser_T1 10-20 NNS denotes signatures
EnjuParser_T2 21-23 IN denotes of
EnjuParser_T3 24-31 JJ denotes ovarian
EnjuParser_T4 32-38 NN denotes cancer
EnjuParser_T5 39-45 NN denotes tumour
EnjuParser_T6 46-57 NN denotes suppression
EnjuParser_T7 58-63 VBG denotes using
EnjuParser_T8 64-71 NN denotes 2D-DIGE
EnjuParser_T9 72-75 CC denotes and
EnjuParser_T10 76-87 NN denotes 2D-LC-MS/MS
EnjuParser_T11 88-92 IN denotes with
EnjuParser_T12 93-99 JJ denotes tandem
EnjuParser_T13 100-104 NN denotes mass
EnjuParser_T14 105-112 NN denotes tagging
EnjuParser_T15 114-124 JJ denotes Epithelial
EnjuParser_T16 125-132 JJ denotes ovarian
EnjuParser_T17 133-139 NN denotes cancer
EnjuParser_T18 140-141 -LRB- denotes (
EnjuParser_T19 141-144 NN denotes EOC
EnjuParser_T20 144-145 -RRB- denotes )
EnjuParser_T21 146-148 VBZ denotes is
EnjuParser_T22 149-152 DT denotes the
EnjuParser_T23 153-157 RBS denotes most
EnjuParser_T24 158-164 JJ denotes common
EnjuParser_T25 165-169 NN denotes form
EnjuParser_T26 170-172 IN denotes of
EnjuParser_T27 173-187 JJ denotes gynaecological
EnjuParser_T28 188-198 NN denotes malignancy
EnjuParser_T29 199-201 IN denotes in
EnjuParser_T30 202-205 DT denotes the
EnjuParser_T31 206-215 JJ denotes developed
EnjuParser_T32 216-221 NN denotes world
EnjuParser_T33 222-225 CC denotes and
EnjuParser_T34 226-229 VBZ denotes has
EnjuParser_T35 230-231 DT denotes a
EnjuParser_T36 232-236 JJ denotes poor
EnjuParser_T37 237-246 NN denotes prognosis
EnjuParser_T38 247-250 IN denotes due
EnjuParser_T39 251-253 TO denotes to
EnjuParser_T40 254-257 PRP-DOLLAR- denotes its
EnjuParser_T41 258-262 JJ denotes late
EnjuParser_T42 263-272 NN denotes detection
EnjuParser_T43 274-285 VBG denotes Identifying
EnjuParser_T44 286-295 JJ denotes molecular
EnjuParser_T45 296-303 NNS denotes markers
EnjuParser_T46 304-306 IN denotes of
EnjuParser_T47 307-310 DT denotes the
EnjuParser_T48 311-318 NN denotes disease
EnjuParser_T49 319-322 MD denotes may
EnjuParser_T50 323-330 VB denotes provide
EnjuParser_T51 331-336 JJ denotes novel
EnjuParser_T52 337-347 NNS denotes approaches
EnjuParser_T53 348-350 TO denotes to
EnjuParser_T54 351-360 NN denotes screening
EnjuParser_T55 361-364 CC denotes and
EnjuParser_T56 365-370 MD denotes could
EnjuParser_T57 371-377 VB denotes enable
EnjuParser_T58 378-386 VBN denotes targeted
EnjuParser_T59 387-396 NN denotes treatment
EnjuParser_T60 397-400 CC denotes and
EnjuParser_T61 401-404 DT denotes the
EnjuParser_T62 405-411 NN denotes design
EnjuParser_T63 412-414 IN denotes of
EnjuParser_T64 415-420 JJ denotes novel
EnjuParser_T65 421-430 NNS denotes therapies
EnjuParser_T66 432-440 IN denotes Although
EnjuParser_T67 441-446 NN denotes blood
EnjuParser_T68 447-449 VBZ denotes is
EnjuParser_T69 450-460 VBN denotes recognized
EnjuParser_T70 461-463 IN denotes as
EnjuParser_T71 464-465 DT denotes a
EnjuParser_T72 466-472 RB denotes highly
EnjuParser_T73 473-482 JJ denotes important
EnjuParser_T74 483-489 NN denotes source
EnjuParser_T75 490-492 IN denotes of
EnjuParser_T76 493-508 JJ denotes disease-related
EnjuParser_T77 509-519 NNS denotes biomarkers
EnjuParser_T78 519-520 -COMMA- denotes ,
EnjuParser_T79 521-524 DT denotes the
EnjuParser_T80 525-535 NN denotes complexity
EnjuParser_T81 536-539 CC denotes and
EnjuParser_T82 540-547 JJ denotes dynamic
EnjuParser_T83 548-553 NN denotes range
EnjuParser_T84 554-556 IN denotes of
EnjuParser_T85 557-564 NN denotes protein
EnjuParser_T86 565-574 NN denotes abundance
EnjuParser_T87 575-577 IN denotes in
EnjuParser_T88 578-582 NN denotes body
EnjuParser_T89 583-589 NNS denotes fluids
EnjuParser_T90 590-593 VBZ denotes has
EnjuParser_T91 594-602 VBN denotes hampered
EnjuParser_T92 603-612 JJ denotes proteomic
EnjuParser_T93 613-622 NN denotes biomarker
EnjuParser_T94 623-632 NN denotes discovery
EnjuParser_T95 633-636 CC denotes and
EnjuParser_T96 637-648 JJ denotes alternative
EnjuParser_T97 649-659 NNS denotes approaches
EnjuParser_T98 660-665 VBG denotes using
EnjuParser_T99 666-670 NN denotes cell
EnjuParser_T100 671-677 NNS denotes models
EnjuParser_T101 678-681 MD denotes may
EnjuParser_T102 682-684 VB denotes be
EnjuParser_T103 685-689 RBR denotes more
EnjuParser_T104 690-700 JJ denotes successful
EnjuParser_T105 702-708 RB denotes Herein
EnjuParser_T106 708-709 -COMMA- denotes ,
EnjuParser_T107 710-712 PRP denotes we
EnjuParser_T108 713-717 VBP denotes have
EnjuParser_T109 718-726 VBN denotes utilized
EnjuParser_T110 727-730 CD denotes two
EnjuParser_T111 731-739 JJ denotes cellular
EnjuParser_T112 740-746 NNS denotes models
EnjuParser_T113 747-749 IN denotes of
EnjuParser_T114 750-753 NN denotes EOC
EnjuParser_T115 753-754 -COMMA- denotes ,
EnjuParser_T116 755-760 WRB denotes where
EnjuParser_T117 761-769 NN denotes transfer
EnjuParser_T118 770-772 IN denotes of
EnjuParser_T119 773-779 JJ denotes normal
EnjuParser_T120 780-790 NN denotes chromosome
EnjuParser_T121 791-793 CD denotes 18
EnjuParser_T122 794-802 NN denotes material
EnjuParser_T123 803-807 IN denotes into
EnjuParser_T124 808-811 DT denotes the
EnjuParser_T125 812-815 NN denotes EOC
EnjuParser_T126 816-820 NN denotes cell
EnjuParser_T127 821-826 NNS denotes lines
EnjuParser_T128 827-835 NN denotes TOV-112D
EnjuParser_T129 836-839 CC denotes and
EnjuParser_T130 840-847 NN denotes TOV-21G
EnjuParser_T131 848-855 VBN denotes induced
EnjuParser_T132 856-858 FW denotes in
EnjuParser_T133 859-864 FW denotes vitro
EnjuParser_T134 865-868 CC denotes and
EnjuParser_T135 869-871 FW denotes in
EnjuParser_T136 872-876 FW denotes vivo
EnjuParser_T137 877-888 NN denotes suppression
EnjuParser_T138 889-891 IN denotes of
EnjuParser_T139 892-897 PRP-DOLLAR- denotes their
EnjuParser_T140 898-910 JJ denotes tumourigenic
EnjuParser_T141 911-920 NN denotes phenotype
EnjuParser_T142 922-923 DT denotes A
EnjuParser_T143 924-935 NN denotes combination
EnjuParser_T144 936-938 IN denotes of
EnjuParser_T145 939-951 JJ denotes quantitative
EnjuParser_T146 952-967 JJ denotes two-dimensional
EnjuParser_T147 968-978 NN denotes difference
EnjuParser_T148 979-982 NN denotes gel
EnjuParser_T149 983-998 NN denotes electrophoresis
EnjuParser_T150 999-1000 -LRB- denotes (
EnjuParser_T151 1000-1007 NN denotes 2D-DIGE
EnjuParser_T152 1007-1008 -RRB- denotes )
EnjuParser_T153 1009-1012 CC denotes and
EnjuParser_T154 1013-1035 JJ denotes two-dimensional-liquid
EnjuParser_T155 1036-1050 NN denotes chromatography
EnjuParser_T156 1051-1057 JJ denotes tandem
EnjuParser_T157 1058-1062 NN denotes mass
EnjuParser_T158 1063-1075 NN denotes spectrometry
EnjuParser_T159 1076-1077 -LRB- denotes (
EnjuParser_T160 1077-1088 NN denotes 2D-LC-MS/MS
EnjuParser_T161 1088-1089 -RRB- denotes )
EnjuParser_T162 1090-1094 IN denotes with
EnjuParser_T163 1095-1101 JJ denotes tandem
EnjuParser_T164 1102-1106 NN denotes mass
EnjuParser_T165 1107-1114 NN denotes tagging
EnjuParser_T166 1115-1116 -LRB- denotes (
EnjuParser_T167 1116-1119 NN denotes TMT
EnjuParser_T168 1119-1120 -RRB- denotes )
EnjuParser_T169 1121-1124 VBD denotes was
EnjuParser_T170 1125-1133 VBN denotes employed
EnjuParser_T171 1134-1136 TO denotes to
EnjuParser_T172 1137-1144 VB denotes examine
EnjuParser_T173 1145-1148 DT denotes the
EnjuParser_T174 1149-1154 JJ denotes whole
EnjuParser_T175 1155-1159 NN denotes cell
EnjuParser_T176 1159-1160 -COMMA- denotes ,
EnjuParser_T177 1161-1169 VBN denotes secreted
EnjuParser_T178 1170-1173 CC denotes and
EnjuParser_T179 1174-1179 JJ denotes crude
EnjuParser_T180 1180-1188 NN denotes membrane
EnjuParser_T181 1189-1198 NNS denotes proteomes
EnjuParser_T182 1199-1201 IN denotes of
EnjuParser_T183 1202-1205 DT denotes the
EnjuParser_T184 1206-1214 JJ denotes parental
EnjuParser_T185 1215-1218 CC denotes and
EnjuParser_T186 1219-1225 JJ denotes hybrid
EnjuParser_T187 1226-1230 NN denotes cell
EnjuParser_T188 1231-1237 NNS denotes models
EnjuParser_T189 1238-1240 TO denotes to
EnjuParser_T190 1241-1249 VB denotes identify
EnjuParser_T191 1250-1264 RB denotes differentially
EnjuParser_T192 1265-1274 VBN denotes expressed
EnjuParser_T193 1275-1283 NNS denotes proteins
EnjuParser_T194 1284-1286 IN denotes as
EnjuParser_T195 1287-1296 JJ denotes potential
EnjuParser_T196 1297-1304 NNS denotes markers
EnjuParser_T197 1305-1307 IN denotes of
EnjuParser_T198 1308-1314 NN denotes tumour
EnjuParser_T199 1315-1326 NN denotes suppression
EnjuParser_T200 1328-1335 NN denotes Protein
EnjuParser_T201 1336-1343 NNS denotes changes
EnjuParser_T202 1344-1346 IN denotes of
EnjuParser_T203 1347-1355 NN denotes interest
EnjuParser_T204 1356-1360 VBD denotes were
EnjuParser_T205 1361-1370 VBN denotes confirmed
EnjuParser_T206 1371-1373 IN denotes by
EnjuParser_T207 1374-1388 NN denotes immunoblotting
EnjuParser_T208 1389-1391 IN denotes in
EnjuParser_T209 1392-1402 JJ denotes additional
EnjuParser_T210 1403-1409 NN denotes hybrid
EnjuParser_T211 1410-1413 CC denotes and
EnjuParser_T212 1414-1423 JJ denotes revertant
EnjuParser_T213 1424-1428 NN denotes cell
EnjuParser_T214 1429-1434 NNS denotes lines
EnjuParser_T215 1435-1440 WRB denotes where
EnjuParser_T216 1441-1453 JJ denotes incorporated
EnjuParser_T217 1454-1464 NN denotes chromosome
EnjuParser_T218 1465-1467 CD denotes 18
EnjuParser_T219 1468-1476 NN denotes material
EnjuParser_T220 1477-1480 VBD denotes was
EnjuParser_T221 1481-1485 VBN denotes lost
EnjuParser_T222 1487-1490 CD denotes One
EnjuParser_T223 1491-1500 NN denotes candidate
EnjuParser_T224 1501-1507 NN denotes marker
EnjuParser_T225 1508-1511 VBD denotes was
EnjuParser_T226 1512-1516 RB denotes also
EnjuParser_T227 1517-1523 VBN denotes tested
EnjuParser_T228 1524-1526 IN denotes in
EnjuParser_T229 1527-1531 NNS denotes sera
EnjuParser_T230 1532-1536 IN denotes from
EnjuParser_T231 1537-1538 DT denotes a
EnjuParser_T232 1539-1542 NN denotes set
EnjuParser_T233 1543-1545 IN denotes of
EnjuParser_T234 1546-1553 JJ denotes ovarian
EnjuParser_T235 1554-1560 NN denotes cancer
EnjuParser_T236 1561-1566 NNS denotes cases
EnjuParser_T237 1567-1570 CC denotes and
EnjuParser_T238 1571-1579 NNS denotes controls
EnjuParser_T239 1581-1583 PRP denotes We
EnjuParser_T240 1584-1588 VBP denotes have
EnjuParser_T241 1589-1599 VBN denotes identified
EnjuParser_T242 1600-1601 DT denotes a
EnjuParser_T243 1602-1606 NN denotes list
EnjuParser_T244 1607-1609 IN denotes of
EnjuParser_T245 1610-1619 JJ denotes promising
EnjuParser_T246 1620-1629 NN denotes candidate
EnjuParser_T247 1630-1640 NNS denotes biomarkers
EnjuParser_T248 1641-1644 IN denotes for
EnjuParser_T249 1645-1652 JJ denotes further
EnjuParser_T250 1653-1660 NN denotes testing
EnjuParser_T251 1661-1664 CC denotes and
EnjuParser_T252 1665-1675 JJ denotes functional
EnjuParser_T253 1676-1692 NN denotes characterization
EnjuParser_R0 EnjuParser_T1 EnjuParser_T0 arg1Of signatures,Profiling
EnjuParser_R1 EnjuParser_T1 EnjuParser_T2 arg1Of signatures,of
EnjuParser_R2 EnjuParser_T6 EnjuParser_T2 arg2Of suppression,of
EnjuParser_R3 EnjuParser_T6 EnjuParser_T3 arg1Of suppression,ovarian
EnjuParser_R4 EnjuParser_T6 EnjuParser_T4 arg1Of suppression,cancer
EnjuParser_R5 EnjuParser_T6 EnjuParser_T5 arg1Of suppression,tumour
EnjuParser_R6 EnjuParser_T1 EnjuParser_T7 arg1Of signatures,using
EnjuParser_R7 EnjuParser_T9 EnjuParser_T7 arg2Of and,using
EnjuParser_R8 EnjuParser_T8 EnjuParser_T9 arg1Of 2D-DIGE,and
EnjuParser_R9 EnjuParser_T10 EnjuParser_T9 arg2Of 2D-LC-MS/MS,and
EnjuParser_R10 EnjuParser_T7 EnjuParser_T11 arg1Of using,with
EnjuParser_R11 EnjuParser_T14 EnjuParser_T11 arg2Of tagging,with
EnjuParser_R12 EnjuParser_T14 EnjuParser_T12 arg1Of tagging,tandem
EnjuParser_R13 EnjuParser_T14 EnjuParser_T13 arg1Of tagging,mass
EnjuParser_R14 EnjuParser_T17 EnjuParser_T15 arg1Of cancer,Epithelial
EnjuParser_R15 EnjuParser_T17 EnjuParser_T16 arg1Of cancer,ovarian
EnjuParser_R16 EnjuParser_T17 EnjuParser_T18 arg1Of cancer,(
EnjuParser_R17 EnjuParser_T19 EnjuParser_T18 arg2Of EOC,(
EnjuParser_R18 EnjuParser_T20 EnjuParser_T18 arg3Of ),(
EnjuParser_R19 EnjuParser_T17 EnjuParser_T21 arg1Of cancer,is
EnjuParser_R20 EnjuParser_T25 EnjuParser_T21 arg2Of form,is
EnjuParser_R21 EnjuParser_T25 EnjuParser_T22 arg1Of form,the
EnjuParser_R22 EnjuParser_T24 EnjuParser_T23 arg1Of common,most
EnjuParser_R23 EnjuParser_T25 EnjuParser_T24 arg1Of form,common
EnjuParser_R24 EnjuParser_T25 EnjuParser_T26 arg1Of form,of
EnjuParser_R25 EnjuParser_T28 EnjuParser_T26 arg2Of malignancy,of
EnjuParser_R26 EnjuParser_T28 EnjuParser_T27 arg1Of malignancy,gynaecological
EnjuParser_R27 EnjuParser_T25 EnjuParser_T29 arg1Of form,in
EnjuParser_R28 EnjuParser_T32 EnjuParser_T29 arg2Of world,in
EnjuParser_R29 EnjuParser_T32 EnjuParser_T30 arg1Of world,the
EnjuParser_R30 EnjuParser_T32 EnjuParser_T31 arg1Of world,developed
EnjuParser_R31 EnjuParser_T21 EnjuParser_T33 arg1Of is,and
EnjuParser_R32 EnjuParser_T34 EnjuParser_T33 arg2Of has,and
EnjuParser_R33 EnjuParser_T17 EnjuParser_T34 arg1Of cancer,has
EnjuParser_R34 EnjuParser_T37 EnjuParser_T34 arg2Of prognosis,has
EnjuParser_R35 EnjuParser_T37 EnjuParser_T35 arg1Of prognosis,a
EnjuParser_R36 EnjuParser_T37 EnjuParser_T36 arg1Of prognosis,poor
EnjuParser_R37 EnjuParser_T39 EnjuParser_T38 arg1Of to,due
EnjuParser_R38 EnjuParser_T37 EnjuParser_T39 arg1Of prognosis,to
EnjuParser_R39 EnjuParser_T42 EnjuParser_T39 arg2Of detection,to
EnjuParser_R40 EnjuParser_T42 EnjuParser_T40 arg1Of detection,its
EnjuParser_R41 EnjuParser_T42 EnjuParser_T41 arg1Of detection,late
EnjuParser_R42 EnjuParser_T45 EnjuParser_T43 arg2Of markers,Identifying
EnjuParser_R43 EnjuParser_T45 EnjuParser_T44 arg1Of markers,molecular
EnjuParser_R44 EnjuParser_T45 EnjuParser_T46 arg1Of markers,of
EnjuParser_R45 EnjuParser_T48 EnjuParser_T46 arg2Of disease,of
EnjuParser_R46 EnjuParser_T48 EnjuParser_T47 arg1Of disease,the
EnjuParser_R47 EnjuParser_T43 EnjuParser_T49 arg1Of Identifying,may
EnjuParser_R48 EnjuParser_T50 EnjuParser_T49 arg2Of provide,may
EnjuParser_R49 EnjuParser_T43 EnjuParser_T50 arg1Of Identifying,provide
EnjuParser_R50 EnjuParser_T52 EnjuParser_T50 arg2Of approaches,provide
EnjuParser_R51 EnjuParser_T52 EnjuParser_T51 arg1Of approaches,novel
EnjuParser_R52 EnjuParser_T52 EnjuParser_T53 arg1Of approaches,to
EnjuParser_R53 EnjuParser_T54 EnjuParser_T53 arg2Of screening,to
EnjuParser_R54 EnjuParser_T50 EnjuParser_T55 arg1Of provide,and
EnjuParser_R55 EnjuParser_T57 EnjuParser_T55 arg2Of enable,and
EnjuParser_R56 EnjuParser_T43 EnjuParser_T56 arg1Of Identifying,could
EnjuParser_R57 EnjuParser_T57 EnjuParser_T56 arg2Of enable,could
EnjuParser_R58 EnjuParser_T43 EnjuParser_T57 arg1Of Identifying,enable
EnjuParser_R59 EnjuParser_T60 EnjuParser_T57 arg2Of and,enable
EnjuParser_R60 EnjuParser_T59 EnjuParser_T58 arg2Of treatment,targeted
EnjuParser_R61 EnjuParser_T59 EnjuParser_T60 arg1Of treatment,and
EnjuParser_R62 EnjuParser_T62 EnjuParser_T60 arg2Of design,and
EnjuParser_R63 EnjuParser_T62 EnjuParser_T61 arg1Of design,the
EnjuParser_R64 EnjuParser_T62 EnjuParser_T63 arg1Of design,of
EnjuParser_R65 EnjuParser_T65 EnjuParser_T63 arg2Of therapies,of
EnjuParser_R66 EnjuParser_T65 EnjuParser_T64 arg1Of therapies,novel
EnjuParser_R67 EnjuParser_T95 EnjuParser_T66 arg1Of and,Although
EnjuParser_R68 EnjuParser_T69 EnjuParser_T66 arg2Of recognized,Although
EnjuParser_R69 EnjuParser_T67 EnjuParser_T68 arg1Of blood,is
EnjuParser_R70 EnjuParser_T69 EnjuParser_T68 arg2Of recognized,is
EnjuParser_R71 EnjuParser_T67 EnjuParser_T69 arg2Of blood,recognized
EnjuParser_R72 EnjuParser_T69 EnjuParser_T70 arg1Of recognized,as
EnjuParser_R73 EnjuParser_T74 EnjuParser_T70 arg2Of source,as
EnjuParser_R74 EnjuParser_T74 EnjuParser_T71 arg1Of source,a
EnjuParser_R75 EnjuParser_T73 EnjuParser_T72 arg1Of important,highly
EnjuParser_R76 EnjuParser_T74 EnjuParser_T73 arg1Of source,important
EnjuParser_R77 EnjuParser_T74 EnjuParser_T75 arg1Of source,of
EnjuParser_R78 EnjuParser_T77 EnjuParser_T75 arg2Of biomarkers,of
EnjuParser_R79 EnjuParser_T77 EnjuParser_T76 arg1Of biomarkers,disease-related
EnjuParser_R80 EnjuParser_T95 EnjuParser_T78 arg1Of and,","
EnjuParser_R81 EnjuParser_T83 EnjuParser_T79 arg1Of range,the
EnjuParser_R82 EnjuParser_T83 EnjuParser_T80 arg1Of range,complexity
EnjuParser_R83 EnjuParser_T80 EnjuParser_T81 arg1Of complexity,and
EnjuParser_R84 EnjuParser_T82 EnjuParser_T81 arg2Of dynamic,and
EnjuParser_R85 EnjuParser_T83 EnjuParser_T82 arg1Of range,dynamic
EnjuParser_R86 EnjuParser_T83 EnjuParser_T84 arg1Of range,of
EnjuParser_R87 EnjuParser_T86 EnjuParser_T84 arg2Of abundance,of
EnjuParser_R88 EnjuParser_T86 EnjuParser_T85 arg1Of abundance,protein
EnjuParser_R89 EnjuParser_T83 EnjuParser_T87 arg1Of range,in
EnjuParser_R90 EnjuParser_T89 EnjuParser_T87 arg2Of fluids,in
EnjuParser_R91 EnjuParser_T89 EnjuParser_T88 arg1Of fluids,body
EnjuParser_R92 EnjuParser_T83 EnjuParser_T90 arg1Of range,has
EnjuParser_R93 EnjuParser_T91 EnjuParser_T90 arg2Of hampered,has
EnjuParser_R94 EnjuParser_T83 EnjuParser_T91 arg1Of range,hampered
EnjuParser_R95 EnjuParser_T94 EnjuParser_T91 arg2Of discovery,hampered
EnjuParser_R96 EnjuParser_T94 EnjuParser_T92 arg1Of discovery,proteomic
EnjuParser_R97 EnjuParser_T94 EnjuParser_T93 arg1Of discovery,biomarker
EnjuParser_R98 EnjuParser_T91 EnjuParser_T95 arg1Of hampered,and
EnjuParser_R99 EnjuParser_T102 EnjuParser_T95 arg2Of be,and
EnjuParser_R100 EnjuParser_T97 EnjuParser_T96 arg1Of approaches,alternative
EnjuParser_R101 EnjuParser_T97 EnjuParser_T98 arg1Of approaches,using
EnjuParser_R102 EnjuParser_T100 EnjuParser_T98 arg2Of models,using
EnjuParser_R103 EnjuParser_T100 EnjuParser_T99 arg1Of models,cell
EnjuParser_R104 EnjuParser_T97 EnjuParser_T101 arg1Of approaches,may
EnjuParser_R105 EnjuParser_T102 EnjuParser_T101 arg2Of be,may
EnjuParser_R106 EnjuParser_T97 EnjuParser_T102 arg1Of approaches,be
EnjuParser_R107 EnjuParser_T104 EnjuParser_T102 arg2Of successful,be
EnjuParser_R108 EnjuParser_T104 EnjuParser_T103 arg1Of successful,more
EnjuParser_R109 EnjuParser_T97 EnjuParser_T104 arg1Of approaches,successful
EnjuParser_R110 EnjuParser_T109 EnjuParser_T105 arg1Of utilized,Herein
EnjuParser_R111 EnjuParser_T109 EnjuParser_T106 arg1Of utilized,","
EnjuParser_R112 EnjuParser_T107 EnjuParser_T108 arg1Of we,have
EnjuParser_R113 EnjuParser_T109 EnjuParser_T108 arg2Of utilized,have
EnjuParser_R114 EnjuParser_T107 EnjuParser_T109 arg1Of we,utilized
EnjuParser_R115 EnjuParser_T115 EnjuParser_T109 arg2Of ",",utilized
EnjuParser_R116 EnjuParser_T112 EnjuParser_T110 arg1Of models,two
EnjuParser_R117 EnjuParser_T112 EnjuParser_T111 arg1Of models,cellular
EnjuParser_R118 EnjuParser_T112 EnjuParser_T113 arg1Of models,of
EnjuParser_R119 EnjuParser_T114 EnjuParser_T113 arg2Of EOC,of
EnjuParser_R120 EnjuParser_T112 EnjuParser_T115 arg1Of models,","
EnjuParser_R121 EnjuParser_T134 EnjuParser_T115 arg2Of and,","
EnjuParser_R122 EnjuParser_T131 EnjuParser_T116 arg1Of induced,where
EnjuParser_R123 EnjuParser_T117 EnjuParser_T118 arg1Of transfer,of
EnjuParser_R124 EnjuParser_T122 EnjuParser_T118 arg2Of material,of
EnjuParser_R125 EnjuParser_T122 EnjuParser_T119 arg1Of material,normal
EnjuParser_R126 EnjuParser_T122 EnjuParser_T120 arg1Of material,chromosome
EnjuParser_R127 EnjuParser_T122 EnjuParser_T121 arg1Of material,18
EnjuParser_R128 EnjuParser_T117 EnjuParser_T123 arg1Of transfer,into
EnjuParser_R129 EnjuParser_T129 EnjuParser_T123 arg2Of and,into
EnjuParser_R130 EnjuParser_T129 EnjuParser_T124 arg1Of and,the
EnjuParser_R131 EnjuParser_T127 EnjuParser_T125 arg1Of lines,EOC
EnjuParser_R132 EnjuParser_T127 EnjuParser_T126 arg1Of lines,cell
EnjuParser_R133 EnjuParser_T129 EnjuParser_T127 arg1Of and,lines
EnjuParser_R134 EnjuParser_T128 EnjuParser_T129 arg1Of TOV-112D,and
EnjuParser_R135 EnjuParser_T130 EnjuParser_T129 arg2Of TOV-21G,and
EnjuParser_R136 EnjuParser_T117 EnjuParser_T131 arg2Of transfer,induced
EnjuParser_R137 EnjuParser_T133 EnjuParser_T132 arg1Of vitro,in
EnjuParser_R138 EnjuParser_T131 EnjuParser_T133 arg1Of induced,vitro
EnjuParser_R139 EnjuParser_T116 EnjuParser_T134 arg1Of where,and
EnjuParser_R140 EnjuParser_T137 EnjuParser_T134 arg2Of suppression,and
EnjuParser_R141 EnjuParser_T136 EnjuParser_T135 arg1Of vivo,in
EnjuParser_R142 EnjuParser_T137 EnjuParser_T136 arg1Of suppression,vivo
EnjuParser_R143 EnjuParser_T137 EnjuParser_T138 arg1Of suppression,of
EnjuParser_R144 EnjuParser_T141 EnjuParser_T138 arg2Of phenotype,of
EnjuParser_R145 EnjuParser_T141 EnjuParser_T139 arg1Of phenotype,their
EnjuParser_R146 EnjuParser_T141 EnjuParser_T140 arg1Of phenotype,tumourigenic
EnjuParser_R147 EnjuParser_T143 EnjuParser_T142 arg1Of combination,A
EnjuParser_R148 EnjuParser_T143 EnjuParser_T144 arg1Of combination,of
EnjuParser_R149 EnjuParser_T153 EnjuParser_T144 arg2Of and,of
EnjuParser_R150 EnjuParser_T149 EnjuParser_T145 arg1Of electrophoresis,quantitative
EnjuParser_R151 EnjuParser_T149 EnjuParser_T146 arg1Of electrophoresis,two-dimensional
EnjuParser_R152 EnjuParser_T149 EnjuParser_T147 arg1Of electrophoresis,difference
EnjuParser_R153 EnjuParser_T149 EnjuParser_T148 arg1Of electrophoresis,gel
EnjuParser_R154 EnjuParser_T149 EnjuParser_T150 arg1Of electrophoresis,(
EnjuParser_R155 EnjuParser_T151 EnjuParser_T150 arg2Of 2D-DIGE,(
EnjuParser_R156 EnjuParser_T152 EnjuParser_T150 arg3Of ),(
EnjuParser_R157 EnjuParser_T149 EnjuParser_T153 arg1Of electrophoresis,and
EnjuParser_R158 EnjuParser_T158 EnjuParser_T153 arg2Of spectrometry,and
EnjuParser_R159 EnjuParser_T158 EnjuParser_T154 arg1Of spectrometry,two-dimensional-liquid
EnjuParser_R160 EnjuParser_T158 EnjuParser_T155 arg1Of spectrometry,chromatography
EnjuParser_R161 EnjuParser_T158 EnjuParser_T156 arg1Of spectrometry,tandem
EnjuParser_R162 EnjuParser_T158 EnjuParser_T157 arg1Of spectrometry,mass
EnjuParser_R163 EnjuParser_T158 EnjuParser_T159 arg1Of spectrometry,(
EnjuParser_R164 EnjuParser_T160 EnjuParser_T159 arg2Of 2D-LC-MS/MS,(
EnjuParser_R165 EnjuParser_T161 EnjuParser_T159 arg3Of ),(
EnjuParser_R166 EnjuParser_T153 EnjuParser_T162 arg1Of and,with
EnjuParser_R167 EnjuParser_T165 EnjuParser_T162 arg2Of tagging,with
EnjuParser_R168 EnjuParser_T165 EnjuParser_T163 arg1Of tagging,tandem
EnjuParser_R169 EnjuParser_T165 EnjuParser_T164 arg1Of tagging,mass
EnjuParser_R170 EnjuParser_T165 EnjuParser_T166 arg1Of tagging,(
EnjuParser_R171 EnjuParser_T167 EnjuParser_T166 arg2Of TMT,(
EnjuParser_R172 EnjuParser_T168 EnjuParser_T166 arg3Of ),(
EnjuParser_R173 EnjuParser_T143 EnjuParser_T169 arg1Of combination,was
EnjuParser_R174 EnjuParser_T170 EnjuParser_T169 arg2Of employed,was
EnjuParser_R175 EnjuParser_T143 EnjuParser_T170 arg2Of combination,employed
EnjuParser_R176 EnjuParser_T172 EnjuParser_T170 arg3Of examine,employed
EnjuParser_R177 EnjuParser_T172 EnjuParser_T171 arg1Of examine,to
EnjuParser_R178 EnjuParser_T178 EnjuParser_T172 arg2Of and,examine
EnjuParser_R179 EnjuParser_T178 EnjuParser_T173 arg1Of and,the
EnjuParser_R180 EnjuParser_T175 EnjuParser_T174 arg1Of cell,whole
EnjuParser_R181 EnjuParser_T175 EnjuParser_T176 arg1Of cell,","
EnjuParser_R182 EnjuParser_T175 EnjuParser_T177 arg2Of cell,secreted
EnjuParser_R183 EnjuParser_T175 EnjuParser_T178 arg1Of cell,and
EnjuParser_R184 EnjuParser_T181 EnjuParser_T178 arg2Of proteomes,and
EnjuParser_R185 EnjuParser_T181 EnjuParser_T179 arg1Of proteomes,crude
EnjuParser_R186 EnjuParser_T181 EnjuParser_T180 arg1Of proteomes,membrane
EnjuParser_R187 EnjuParser_T181 EnjuParser_T182 arg1Of proteomes,of
EnjuParser_R188 EnjuParser_T188 EnjuParser_T182 arg2Of models,of
EnjuParser_R189 EnjuParser_T188 EnjuParser_T183 arg1Of models,the
EnjuParser_R190 EnjuParser_T188 EnjuParser_T184 arg1Of models,parental
EnjuParser_R191 EnjuParser_T184 EnjuParser_T185 arg1Of parental,and
EnjuParser_R192 EnjuParser_T186 EnjuParser_T185 arg2Of hybrid,and
EnjuParser_R193 EnjuParser_T188 EnjuParser_T186 arg1Of models,hybrid
EnjuParser_R194 EnjuParser_T188 EnjuParser_T187 arg1Of models,cell
EnjuParser_R195 EnjuParser_T190 EnjuParser_T189 arg1Of identify,to
EnjuParser_R196 EnjuParser_T181 EnjuParser_T189 modOf proteomes,to
EnjuParser_R197 EnjuParser_T193 EnjuParser_T190 arg2Of proteins,identify
EnjuParser_R198 EnjuParser_T192 EnjuParser_T191 arg1Of expressed,differentially
EnjuParser_R199 EnjuParser_T193 EnjuParser_T192 arg1Of proteins,expressed
EnjuParser_R200 EnjuParser_T190 EnjuParser_T194 arg1Of identify,as
EnjuParser_R201 EnjuParser_T196 EnjuParser_T194 arg2Of markers,as
EnjuParser_R202 EnjuParser_T196 EnjuParser_T195 arg1Of markers,potential
EnjuParser_R203 EnjuParser_T196 EnjuParser_T197 arg1Of markers,of
EnjuParser_R204 EnjuParser_T199 EnjuParser_T197 arg2Of suppression,of
EnjuParser_R205 EnjuParser_T199 EnjuParser_T198 arg1Of suppression,tumour
EnjuParser_R206 EnjuParser_T201 EnjuParser_T200 arg1Of changes,Protein
EnjuParser_R207 EnjuParser_T201 EnjuParser_T202 arg1Of changes,of
EnjuParser_R208 EnjuParser_T203 EnjuParser_T202 arg2Of interest,of
EnjuParser_R209 EnjuParser_T201 EnjuParser_T204 arg1Of changes,were
EnjuParser_R210 EnjuParser_T205 EnjuParser_T204 arg2Of confirmed,were
EnjuParser_R211 EnjuParser_T207 EnjuParser_T205 arg1Of immunoblotting,confirmed
EnjuParser_R212 EnjuParser_T201 EnjuParser_T205 arg2Of changes,confirmed
EnjuParser_R213 EnjuParser_T207 EnjuParser_T206 arg2Of immunoblotting,by
EnjuParser_R214 EnjuParser_T207 EnjuParser_T208 arg1Of immunoblotting,in
EnjuParser_R215 EnjuParser_T211 EnjuParser_T208 arg2Of and,in
EnjuParser_R216 EnjuParser_T210 EnjuParser_T209 arg1Of hybrid,additional
EnjuParser_R217 EnjuParser_T210 EnjuParser_T211 arg1Of hybrid,and
EnjuParser_R218 EnjuParser_T214 EnjuParser_T211 arg2Of lines,and
EnjuParser_R219 EnjuParser_T214 EnjuParser_T212 arg1Of lines,revertant
EnjuParser_R220 EnjuParser_T214 EnjuParser_T213 arg1Of lines,cell
EnjuParser_R221 EnjuParser_T211 EnjuParser_T215 arg1Of and,where
EnjuParser_R222 EnjuParser_T221 EnjuParser_T215 arg2Of lost,where
EnjuParser_R223 EnjuParser_T219 EnjuParser_T216 arg1Of material,incorporated
EnjuParser_R224 EnjuParser_T219 EnjuParser_T217 arg1Of material,chromosome
EnjuParser_R225 EnjuParser_T219 EnjuParser_T218 arg1Of material,18
EnjuParser_R226 EnjuParser_T219 EnjuParser_T220 arg1Of material,was
EnjuParser_R227 EnjuParser_T221 EnjuParser_T220 arg2Of lost,was
EnjuParser_R228 EnjuParser_T219 EnjuParser_T221 arg2Of material,lost
EnjuParser_R229 EnjuParser_T224 EnjuParser_T222 arg1Of marker,One
EnjuParser_R230 EnjuParser_T224 EnjuParser_T223 arg1Of marker,candidate
EnjuParser_R231 EnjuParser_T224 EnjuParser_T225 arg1Of marker,was
EnjuParser_R232 EnjuParser_T227 EnjuParser_T225 arg2Of tested,was
EnjuParser_R233 EnjuParser_T227 EnjuParser_T226 arg1Of tested,also
EnjuParser_R234 EnjuParser_T224 EnjuParser_T227 arg2Of marker,tested
EnjuParser_R235 EnjuParser_T227 EnjuParser_T228 arg1Of tested,in
EnjuParser_R236 EnjuParser_T229 EnjuParser_T228 arg2Of sera,in
EnjuParser_R237 EnjuParser_T229 EnjuParser_T230 arg1Of sera,from
EnjuParser_R238 EnjuParser_T232 EnjuParser_T230 arg2Of set,from
EnjuParser_R239 EnjuParser_T232 EnjuParser_T231 arg1Of set,a
EnjuParser_R240 EnjuParser_T232 EnjuParser_T233 arg1Of set,of
EnjuParser_R241 EnjuParser_T237 EnjuParser_T233 arg2Of and,of
EnjuParser_R242 EnjuParser_T236 EnjuParser_T234 arg1Of cases,ovarian
EnjuParser_R243 EnjuParser_T236 EnjuParser_T235 arg1Of cases,cancer
EnjuParser_R244 EnjuParser_T236 EnjuParser_T237 arg1Of cases,and
EnjuParser_R245 EnjuParser_T238 EnjuParser_T237 arg2Of controls,and
EnjuParser_R246 EnjuParser_T239 EnjuParser_T240 arg1Of We,have
EnjuParser_R247 EnjuParser_T241 EnjuParser_T240 arg2Of identified,have
EnjuParser_R248 EnjuParser_T239 EnjuParser_T241 arg1Of We,identified
EnjuParser_R249 EnjuParser_T243 EnjuParser_T241 arg2Of list,identified
EnjuParser_R250 EnjuParser_T243 EnjuParser_T242 arg1Of list,a
EnjuParser_R251 EnjuParser_T243 EnjuParser_T244 arg1Of list,of
EnjuParser_R252 EnjuParser_T247 EnjuParser_T244 arg2Of biomarkers,of
EnjuParser_R253 EnjuParser_T247 EnjuParser_T245 arg1Of biomarkers,promising
EnjuParser_R254 EnjuParser_T247 EnjuParser_T246 arg1Of biomarkers,candidate
EnjuParser_R255 EnjuParser_T247 EnjuParser_T248 arg1Of biomarkers,for
EnjuParser_R256 EnjuParser_T251 EnjuParser_T248 arg2Of and,for
EnjuParser_R257 EnjuParser_T250 EnjuParser_T249 arg1Of testing,further
EnjuParser_R258 EnjuParser_T250 EnjuParser_T251 arg1Of testing,and
EnjuParser_R259 EnjuParser_T253 EnjuParser_T251 arg2Of characterization,and
EnjuParser_R260 EnjuParser_T253 EnjuParser_T252 arg1Of characterization,functional

Anatomy-MAT

Id Subject Object Predicate Lexical cue mat_id
T1 441-446 Body_part denotes blood http://purl.obolibrary.org/obo/MAT_0000083|http://purl.obolibrary.org/obo/MAT_0000315

mondo_disease

Id Subject Object Predicate Lexical cue mondo_id
T1 24-38 Disease denotes ovarian cancer http://purl.obolibrary.org/obo/MONDO_0008170
T2 114-139 Disease denotes Epithelial ovarian cancer http://purl.obolibrary.org/obo/MONDO_0018364
T3 141-144 Disease denotes EOC http://purl.obolibrary.org/obo/MONDO_0018364
T4 750-753 Disease denotes EOC http://purl.obolibrary.org/obo/MONDO_0018364
T5 812-815 Disease denotes EOC http://purl.obolibrary.org/obo/MONDO_0018364
T6 1546-1560 Disease denotes ovarian cancer http://purl.obolibrary.org/obo/MONDO_0008170

Anatomy-UBERON

Id Subject Object Predicate Lexical cue uberon_id
T1 441-446 Body_part denotes blood http://purl.obolibrary.org/obo/UBERON_0000178
T2 578-589 Body_part denotes body fluids http://purl.obolibrary.org/obo/UBERON_0006314
T3 780-790 Body_part denotes chromosome http://purl.obolibrary.org/obo/GO_0005694
T4 1180-1188 Body_part denotes membrane http://purl.obolibrary.org/obo/GO_0016020|http://purl.obolibrary.org/obo/UBERON_0000094|http://purl.obolibrary.org/obo/UBERON_0000158
T7 1454-1464 Body_part denotes chromosome http://purl.obolibrary.org/obo/GO_0005694

GlyCosmos15-HP

Id Subject Object Predicate Lexical cue hp_id
T1 24-38 Phenotype denotes ovarian cancer HP:0100615
T2 39-45 Phenotype denotes tumour HP:0002664
T3 125-139 Phenotype denotes ovarian cancer HP:0100615
T4 1308-1314 Phenotype denotes tumour HP:0002664
T5 1546-1560 Phenotype denotes ovarian cancer HP:0100615